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lowed the left atrial electrogram recorded within a PV. 
Results: Electrical isolation was achieved in 56 of 62 left superior PVs (LSPV, 90%). 58 
of 62 right superior PVs (RSPV, 95%) 54 of 60 left inferior PVs (LIPV, 90%) and 14 of 14 
right inferior PVs (RIPV, 100%). After isolation, there were residual low-amplitude, low- 
frequency potentials in 32% of the LSPVs, 16% of the RSPVs. 16% of the LIPVs, and in 
none of the RiPVs. Among the 46 of 62 patients who had complete isolation of all tar- 
geted PVs, there was a residual potential in at least 1 PV in 22 patients (46%). After 55 * 
42 days of follow-up. there was a recurrence of atrial fibrillation in 12 of 31 patients (39%) 
with and in 10 of 31 patients (32%) without residual potentials (p=O.6). Total duration of 
RF energy application was 23.1 f 10.6 and 16.3 + 6.7minutes in patients with and without 
residual potentials (p=O.OB). 
Conciuelons: Low-amplitude and low-frequency residual potentials are occasionally 
observed after PV isolation. These potentials do not predict recurrence of atrial fibriila- 
hon. Attempts to ablate these potentials may result in unnecessary applications of RF 
energy. 
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Background: Current approaches to atriai fibrillation (AF) ablation seek to eliminate crit- 
ical connections between left atrlal substrate and arrhythmogenic pulmonary vein (PV) 
triggers. PV potentials can be mapped and eliminated with a limited number of lesions, 
but this approach has limitations due to highly variable PV geometry and muscle fiber 
distributionwe evaluated the relationship of PV potentials to voltage abatment around 
PV ostia obtained by circumferential radiofrequency ablation. Methods: Circumferential 
PV ablation using 3D eiectroanatomicai guidance was performed in 251 patients with 
paroxysmal (n=179) or permanent (n=72) AF. Endpoint for lesion completeness was 
bipolar electrogram amplitude ~0.1 mV inside the circular line. Reeults: Among 960 
lesions surrounding individual PVs (n=956) or 2 ipsilaterai veins with close openings or 
common ostium (n=24). 75% were complete. In preablation maps, PV potentials pre- 
ceded by far-field atrial activity were detected in 401/1146 (35%) near-ostiai points. This 
pattern was mostly observed in superior PVs (superoiateral, n=QQ [BO%]); superoseptai, 
n=62 [67%]) and less frequently in inferior veins (inferolaterai, n=61 [49%]; inferoseptal. 
n=25 [20%]). In postablation maps, PV potentials were not recorded in any of the corn- 
piete lesions, whereas they were found in 106 of 270 incomplete lesions. At 10.4i4.5 
month follow-up, proportion of PVs with complete lesions was similar between patients 
with (n=50) and without (n=201) recurrence. Conclusions: Absence of discrete electrical 
activity within circular lesions correlated with PV potential abolition but not with AF recur- 
rence, suggesting that circumferential PV ablation may alter critical pathways, cardiac 
innervation and other undefined factors to modify AF frequency and physiology beyond 
PV disarticuiation. 
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Background: Focal ablation and pulmonary vein(PV) isolation have both been advocated 
as catheter based procedures that can eliminate PV triggers for paroxysmal atral fibriiia- 
tion (PAF). Methods: We compared the outcome following focal (n=42 pts) versus PV iso- 
lation (~41 pts) for frequent drug refractory PAF with triggers isolated to PVs. To provide 
a fair comparison of the two techniques and to decrease the influence of a learning curve 
on outcome: 1) the results represent our single center experience with only the outcome 
of a single operator with z-30 PAF ablation procedures included; 2) the outcome of the 
first 10 pts undergoing focal ablation ware excluded; and 3) only short-term results were 
compared (EP lab negative response to isoproterenol and/or cardioversion and 2 month 
follow up after hospitalization). Only PV with atrial fibrillation triggers documented using 
multipolar catheter recording techniques were targeted during both types of ablation 
strategies. All ablation sites for both techniques were documented and tagged using 
eiectroanatomic mapping. Results: All patients had frequent (mediawdaily with range of 
daily to once/week) symptomatic PAF and had failed a median of 4 drugs. See Table. 
Conclusions: PV isolation appears to facilitate acute elimination of focal triggers originat- 
ing from PVs. This beneficial effect appears more marginal at 2 mos for prevention of AF. 
Both PV isolation and focal trigger ablation can be performed with a low serious compii- 
cation rate. 






PAF from PV at end of EP 
PAF at 2 mos 
PV stenosis, Stroke, tamoonade 
50+12 52*12 
4.3 * 0.7 4.3 + 0.6 
5/32 (16%) i/41 (2%) 
1 O/27 (37%) 6/40 (20%) 
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